Literature DB >> 17639595

Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia).

Donna Krasnewich1, Kevin O'Brien, Susan Sparks.   

Abstract

Congenital disorders of glycosylation (CDG) are a group of metabolic disorders resulting from defective synthesis of N-linked oligosaccharides. CDG-Ia is the most common of the 21 known types defined by defects in different steps of the synthetic pathway. An increasing number of American adults with CDG-Ia are being recognized but little is documented on the morbidity and mortality in this population. These adults have moderate mental retardation, ataxia, retinitis pigmentosa, peripheral neuropathy, kyphoscoliosis, and endocrinopathies. Four adults with CDG-Ia, ages 19-36 years old are presented. All are active, dysarthric conversant adults with moderate cognitive impairment. They are ataxic and wheelchair dependent, however, only the oldest man shows significant muscle atrophy. All have diagnosed peripheral neuropathy. Three of four remain on anticonvulsants with only occasional seizures, none have had stroke-like episodes since their teen years. Their skeletal issues include significant kyphoscoliosis, joint contractures, and osteopenia. Retinitis pigmentosa and myopia complicate their functional vision. The women do not menstruate and the men have small testes resulting from hypogonadotropic hypogonadism. Documentation of clinical complications and successful management strategies in adults with CDG will improve their quality of life and allow more informed prognostic discussions with families of younger affected individuals. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17639595     DOI: 10.1002/ajmg.c.30143

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  18 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.

Authors:  Dorothy A Thompson; Ruth J Lyons; Isabelle Russell-Eggitt; Alki Liasis; Herbert Jägle; Stephanie Grünewald
Journal:  J Inherit Metab Dis       Date:  2013-02-22       Impact factor: 4.982

Review 3.  Congenital disorders of glycosylation.

Authors:  Irene J Chang; Miao He; Christina T Lam
Journal:  Ann Transl Med       Date:  2018-12

4.  Defective mucin-type glycosylation on α-dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases.

Authors:  Seok-Ho Yu; Peng Zhao; Pradeep K Prabhakar; Tiantian Sun; Aaron Beedle; Geert-Jan Boons; Kelley W Moremen; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2018-07-26       Impact factor: 5.157

Review 5.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

6.  ST3GAL3 mutations impair the development of higher cognitive functions.

Authors:  Hao Hu; Katinka Eggers; Wei Chen; Masoud Garshasbi; M Mahdi Motazacker; Klaus Wrogemann; Kimia Kahrizi; Andreas Tzschach; Masoumeh Hosseini; Ideh Bahman; Tim Hucho; Martina Mühlenhoff; Rita Gerardy-Schahn; Hossein Najmabadi; H Hilger Ropers; Andreas W Kuss
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

7.  Factor VIII and vWF deficiency in STT3A-CDG.

Authors:  Irene J Chang; Heather M Byers; Bobby G Ng; John Lawrence Merritt; Reid Gilmore; Shiteshu Shrimal; Wei Wei; Yuan Zhang; Amanda B Blair; Hudson H Freeze; Bin Zhang; Christina Lam
Journal:  J Inherit Metab Dis       Date:  2019-01-30       Impact factor: 4.982

Review 8.  Mental retardation and inborn errors of metabolism.

Authors:  A García-Cazorla; N I Wolf; M Serrano; U Moog; B Pérez-Dueñas; P Póo; M Pineda; J Campistol; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-14       Impact factor: 4.982

Review 9.  Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update.

Authors:  Jan Verheijen; Shawn Tahata; Tamas Kozicz; Peter Witters; Eva Morava
Journal:  Genet Med       Date:  2019-09-19       Impact factor: 8.822

10.  Congenital protein hypoglycosylation diseases.

Authors:  Susan E Sparks
Journal:  Appl Clin Genet       Date:  2012-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.